MDxHealth SA (MDXH) Stock

Healthcare · Diagnostics & Research · Member of Other US Stocks

MDxHealth SA (MDXH) closed at USD 0.63 on 2026-10-14, a change of -87.4 % over the past year, with a market capitalization of USD 57.59M.

MDxHealth SA recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

MDxHealth SA key figures

Previous close

USD 0.63 (2026-10-14)

1-year change

-87.4 %

Market cap

USD 57.59M

Enterprise value

USD 117.64M

P/E ratio (trailing)

-0.94

P/E ratio (forward)

-1.59

EPS (trailing)

-0.64

EPS (forward)

-0.38

PEG ratio

n/a

Price to book

-1.02

Revenue growth

2.3 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

5.92

Employees

364

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About MDxHealth SA

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; ExoD, a non-invasive urine test to assess risk of having clinically prostate cancer; and Resolve mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection. It offers genomic prostate score, which provides personalized genomic insights to physicians and patients navigating the complexities of prostate cancer diagnosis and treatment. The company sells its products through urology sales force consisting of direct sales representatives, strategic account managers, and regional sales managers. The company has a collaboration the initiation of Genomic Prostate Score (GPS) testing. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for MDxHealth SA and compare it with other stocks.